NASDAQ: LTRNLantern Pharma Inc Stock Ownership - Who owns Lantern Pharma?
Insider buying vs selling
Have Lantern Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| D. Jeffrey Keyser | Director | 2026-05-12 | 48,544 | $2.06 | $100.00kBuy |
| Lee Troy Schalop | Director | 2026-05-12 | 48,544 | $2.06 | $100.00kBuy |
| Leslie W. Kreis | 10% Owner | 2025-06-13 | 1,903 | $3.09 | $5.88kSell |
| Leslie W. Kreis | 10% Owner | 2025-06-13 | 14,218 | $3.09 | $43.93kSell |
| Leslie W. Kreis | 10% Owner | 2025-06-13 | 4,354 | $3.09 | $13.45kSell |
| Leslie W. Kreis | 10% Owner | 2025-06-13 | 7,206 | $3.09 | $22.27kSell |
| Leslie W. Kreis | 10% Owner | 2025-06-13 | 12,319 | $3.09 | $38.07kSell |
| Aaron Gl Fletcher | 10% Owner | 2025-06-13 | 4,354 | $3.09 | $13.45kSell |
| Aaron Gl Fletcher | 10% Owner | 2025-06-13 | 14,218 | $3.09 | $43.93kSell |
| Aaron Gl Fletcher | 10% Owner | 2025-06-13 | 12,319 | $3.09 | $38.07kSell |
LTRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LTRN insiders and whales buy or sell their stock.
LTRN Shareholders
What type of owners hold Lantern Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Leslie W. Kreis | 26.17% | 2,958,970 | $9.82M | Insider |
| Aaron Gl Fletcher | 9.52% | 1,075,952 | $3.57M | Insider |
| David S. Silberstein | 9.24% | 1,044,000 | $3.47M | Insider |
| Biological Mimetics Inc | 9.24% | 1,044,000 | $3.47M | Insider |
| Bios Capital Management LP | 7.65% | 864,435 | $2.87M | Institution |
| Arunkumar Asaithambi | 3.91% | 441,960 | $1.47M | Insider |
| Vanguard Capital Management LLC | 2.94% | 332,079 | $1.10M | Institution |
| CM Management LLC | 2.21% | 250,000 | $830.00k | Institution |
| Green Park Golf Ventures II LLC | 1.16% | 131,697 | $437.23k | Insider |
| Renaissance Technologies LLC | 1.03% | 116,000 | $385.12k | Institution |
LTRN vs Biotech Stocks
Lantern Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.